Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Más filtros

Medicinas Complementárias
Tipo del documento
Intervalo de año de publicación
1.
Explore (NY) ; 20(2): 256-260, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-37612160

RESUMEN

BACKGROUND: Adult-onset Still's disease (AOSD) is a rare yet well-documented polygenic and systemic autoinflammatory disease characterized by recurrent spiking fever, transient skin rash, arthralgia, and sore throat. Traditional Chinese medicine (TCM) holds a significant role in complementary and alternative medicine. This study presents a unique case of a female AOSD patient with concurrent Qi and fluid deficiency syndrome who received combined treatment with formulated Zhu Ye Shi Gao Decoction (ZYSGD). CASE PRESENTATION: In this case, a 28-year-old female patient presented with a 15-day history of fever and skin rash accompanied by sore throat, fatigue, myalgia, and arthralgia. Additionally, leucocytosis, aminotransferase abnormalities, and elevated inflammatory factor levels were observed. Infectious diseases, solid tumors, and hematological disorders were all ruled out. Anti-infective treatments proved ineffective, leading to the final diagnosis of AOSD. Glucocorticoid therapy provided only partial relief. Consequently, formulated ZYSGD and hepatoprotective drugs were added to the glucocorticoid treatment. Subsequently, the patient's symptoms and inflammatory biomarkers showed improvement. After discharge, the patient's condition remained stable while continuing the formulated ZYSGD in combination with 4 mg of Medrolol (qd) during a 10-month follow-up period. CONCLUSION: This case report suggests that formulated ZYSGD could be a viable option for complementary and alternative therapy for late-stage AOSD, especially in cases involving both Qi and body fluid imbalances.


Asunto(s)
Exantema , Faringitis , Enfermedad de Still del Adulto , Adulto , Humanos , Femenino , Medicina Tradicional China , Enfermedad de Still del Adulto/tratamiento farmacológico , Enfermedad de Still del Adulto/complicaciones , Glucocorticoides/uso terapéutico , Qi , Exantema/complicaciones , Faringitis/complicaciones , Artralgia/complicaciones
2.
Am J Trop Med Hyg ; 104(3): 842-847, 2020 12 14.
Artículo en Inglés | MEDLINE | ID: mdl-33319727

RESUMEN

Timely diagnosis of group A streptococcal (GAS) sore throat coupled with appropriate antibiotic treatment is necessary to prevent serious post-streptococcal complications, including rheumatic fever (RF) and rheumatic heart disease (RHD). Traditional medicine (TM) is a known common adjunct to formal medical care in sub-Saharan Africa. A better understanding of health-seeking behavior for sore throat both within and outside the formal medical system is critical to improving primary prevention efforts of RF and RHD. A prospective mixed-methods study on the use of TM for sore throat was embedded within a larger epidemiological study of RF in Northern Uganda. Children presenting with symptoms of RF were interviewed about recent TM use as well as health services use for sore throat. One hundred children with a median age of 10 years (interquartile range: 6.8-13 years) completed the TM interview with their parent/guardian as part of a research study of RF. Seventeen, or 17%, accessed a TM provider for sore throat as part of the current illness, and 70% accessed TM for sore throat in the past (73% current or past use). Of the 20 parents who witnessed the TM visit, 100% reported use of crude tonsillectomy. Penicillin was the most frequently prescribed medication by TM providers in 52% of participants who were seen by a TM provider. The use of TM among children presenting with symptoms of sore throat in northern Uganda is common and frequently used in tandem with diagnostic services offered through the formal healthcare system. Engagement with TM practitioners may provide an important avenue for designing effective primary prevention and management strategies of RF and reduce the global burden of RHD.


Asunto(s)
Medicinas Tradicionales Africanas , Aceptación de la Atención de Salud , Faringitis/terapia , Fiebre Reumática/diagnóstico , Adolescente , Niño , Femenino , Humanos , Masculino , Aceptación de la Atención de Salud/etnología , Aceptación de la Atención de Salud/estadística & datos numéricos , Faringitis/complicaciones , Fiebre Reumática/etiología , Tonsilectomía/métodos , Uganda
3.
Ital J Pediatr ; 46(1): 106, 2020 Jul 25.
Artículo en Inglés | MEDLINE | ID: mdl-32711565

RESUMEN

BACKGROUND: Despite to PFAPA syndrome is considered a benign and self-limited condition in childhood its impact on patients and families can be remarkable in many cases. Currently, the therapeutic options for managing are non-specific and no consensus exists about the best treatment to use. Pidotimod has been suggested as a new potential treatment in PFAPA syndrome for its immunodulatory effects. We conducted a preliminary, prospective, controlled, open, cross-over trial to assess the efficacy and the safety of Pidotimod in the treatment of children with PFAPA syndrome. METHODS: 22 children with PFAPA syndrome were randomly allocated to treatment with pidotimod (with 2 vials of 400 mg daily) in combination with betamethasone 0.5-1 mg on need, based on parents/caregivers' decision (group A) or betamethasone 0.5-1 mg on need, based on parents/caregivers' decision (group B). Each treatment period was for 3 months (Phase 1), after that patients were switched to the other arm for other 3 months (Phase 2). Efficacy was expressed in terms of number of episodes of fever, pharyngitis, or aphthous stomatitis, as well as the additional use of betamethasone on need. Safety and tolerability of the Pidotimod were evaluated on the basis of the number and type of adverse events (AEs) recorded during the treatment. RESULTS: Patients receiving Pidotimod and use betametasone showed a significant decrease in frequency of fevers (p = 0.002); number of episodes of pharyngitis (p = 0.049); aphthous stomatitis (p = 0.036) as well as the betamethasone use on need (p = 0.007). Overall, 19/22 (86.4%) showed benefits from Pidotimod administration. The safety profile of Pidotimod was excellent as no serious adverse events have been reported in the treated groups. CONCLUSIONS: We firstly showed that high dosage of Pidotimod could be an effective and safe to reduce the PFAPA attacks in children.


Asunto(s)
Fiebre Mediterránea Familiar/tratamiento farmacológico , Factores Inmunológicos/administración & dosificación , Linfadenitis/tratamiento farmacológico , Faringitis/tratamiento farmacológico , Ácido Pirrolidona Carboxílico/análogos & derivados , Estomatitis Aftosa/tratamiento farmacológico , Tiazolidinas/administración & dosificación , Betametasona/administración & dosificación , Niño , Preescolar , Estudios Cruzados , Fiebre Mediterránea Familiar/complicaciones , Femenino , Glucocorticoides/administración & dosificación , Humanos , Linfadenitis/complicaciones , Masculino , Faringitis/complicaciones , Estudios Prospectivos , Ácido Pirrolidona Carboxílico/administración & dosificación , Estomatitis Aftosa/complicaciones , Síndrome , Resultado del Tratamiento
5.
Clin Rheumatol ; 33(7): 893-901, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24894108

RESUMEN

Acute rheumatic fever (ARF) is a non-suppurative complication of pharyngeal infection with group A streptococcus. Signs and symptoms of ARF develop 2 to 3 weeks following pharyngitis and include arthritis, carditis, chorea, subcutaneous nodules, and erythema marginatum. In developing areas of the world, ARF and rheumatic heart disease are estimated to affect nearly 20 million people and remain leading causes of cardiovascular death during the first five decades of life. ARF still represents one of the quintessential examples of a pathogenic trigger culminating in autoimmune manifestations. In this review, we will focus on the pathogenesis and etiology of ARF and its complications, along with diagnostic and treatment approaches to both ameliorate and prevent long-term sequelae of this potentially debilitating disease.


Asunto(s)
Enfermedades Autoinmunes/inmunología , Enfermedades Autoinmunes/microbiología , Fiebre Reumática/inmunología , Fiebre Reumática/microbiología , Infecciones Estreptocócicas/inmunología , Infecciones Estreptocócicas/microbiología , Streptococcus pyogenes/patogenicidad , Antibacterianos/uso terapéutico , Artritis/complicaciones , Artritis/microbiología , Autoinmunidad/inmunología , Corea/complicaciones , Corea/microbiología , Eritema/complicaciones , Eritema/microbiología , Humanos , Inflamación , Microbiota , Miocarditis/complicaciones , Miocarditis/microbiología , Faringitis/complicaciones , Faringitis/microbiología , Enfermedades Reumáticas , Cardiopatía Reumática/complicaciones , Cardiopatía Reumática/microbiología
7.
Eur J Med Res ; 11(1): 20-6, 2006 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-16504956

RESUMEN

OBJECTIVE: This randomised, double-blind, parallel group phase II/III study with adaptive two-stage design and interim analysis compared the efficacy and tolerability of spray (containing a Salvia officinalis fluid extract) against placebo in the treatment of patients with acute viral pharyngitis. - STUDY PARTICIPANTS: in two study parts, a total of 286 patients with subjective and objective evidence of pharyngitis were randomized. In the first study part 122 patients were enrolled. In the second study part 164 patients were included. The treatment duration per patient was 3 days, including one baseline visit and one final visit. - MAIN OUTCOME MEASURES: Area under Curve for change of throat pain intensity (spontaneous pain), documented every 15 minutes within the first 2 hours after the first application as compared to baseline using a visual analog scale (VAS 100 mm). - RESULTS: Following the interim analyses of the first study part the 15 % spray containing 140 microl sage extract per dose was the most promising preparation for the second study part (main study) whereas for the 30% and the 5% preparation results made superiority over placebo unlikely in the final analysis. Overall, the 15 % spray was significantly superior to placebo for the primary efficacy variable with regard to a reduction of the throat pain intensity score. Only minor side effects such as dry pharynx or burning of mild intensity were seen. - CONCLUSIONS: The efficacy and tolerability profile of a 15 % sage spray indicated that this preparation provides a convenient and safe treatment for patients with acute pharyngitis. A symptomatic relief occurred within the first two hours after first administration and was statistically significantly superior to placebo.


Asunto(s)
Dolor/tratamiento farmacológico , Faringitis/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/administración & dosificación , Extractos Vegetales/uso terapéutico , Proyectos de Investigación , Salvia officinalis/química , Enfermedad Aguda , Administración Oral , Adolescente , Adulto , Anciano , Analgésicos/administración & dosificación , Analgésicos/efectos adversos , Analgésicos/uso terapéutico , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Humanos , Persona de Mediana Edad , Dolor/complicaciones , Dimensión del Dolor/efectos de los fármacos , Faringitis/complicaciones , Placebos , Extractos Vegetales/efectos adversos , Plantas Medicinales/efectos adversos , Plantas Medicinales/química , Salvia officinalis/efectos adversos
8.
J Prev Med Hyg ; 47(4): 146-50, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17263161

RESUMEN

INTRODUCTION: Hearing is foundamental for human social life. Secretory Otitis Media (SOM) is the most important cause of trasmissive hypoacusis in early childhood. METHODS: The Department of Physiopathology, Experimental Medicine and Public Health of Siena University in collaboration with the Thermal Baths "Bagni delle Galleraie" proposed a prevention and cure campaign of rhinogenous deafness in June 2002 in some primary schools in the Colle val D'Elsa district. A sample of 87 children was involved in the study (average age of 5,64 +/- 1,41 years). On entering the thermal baths a questionnaire was administered to the parents, to point out possible risk factors. RESULTS: Among the 87 children, 28 cases of SOM and 21 cases of severe tubal disorder were found. Only 19 cases out of 49 were already known to the parents and only 28 joined the study and were examined for three years consecutively. DISCUSSION: Out of the 35 children examined in 2002, 28 returned to "The Galleraie" for the two following years. They repeated the thermal cure for two years as a preventive measure. At present they are not affected by SOM and during the winters suffered a lower number of infections in the primary airways and took less antibiotics. CONCLUSIONS: Our study focuses on infant school children because of their critical age for linguistic and social development. Early diagnosis and therapy prevent any negative social development.


Asunto(s)
Trastornos de la Articulación/prevención & control , Balneología , Pérdida Auditiva/terapia , Otitis Media con Derrame/complicaciones , Otitis Media Supurativa/complicaciones , Trastornos de la Articulación/etiología , Percepción Auditiva/fisiología , Niño , Desarrollo Infantil , Preescolar , Trompa Auditiva/fisiopatología , Femenino , Pérdida Auditiva/etiología , Pérdida Auditiva/prevención & control , Humanos , Italia/epidemiología , Masculino , Faringitis/complicaciones , Servicios de Salud Escolar , Aislamiento Social/psicología , Percepción del Habla/fisiología , Tonsilitis/complicaciones , Resultado del Tratamiento
9.
Paediatr Drugs ; 4(11): 747-54, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12390046

RESUMEN

The objective of this review is to examine the use of short-course antibacterial therapy of group A beta-hemolytic streptococcal (GABHS) pharyngotonsillitis, compared with traditional 10-day therapy. In preparing this paper we reviewed the medical literature of studies comparing 10 days of penicillin with shorter courses of antibacterial therapy. Short-course therapy of 6 days of amoxicillin, 4 to 5 days of cephalosporins, and 5 days of azithromycin was found to be as, or more effective than traditional 10-day penicillin therapy. The benefits of short-course therapy include superior compliance and adherence, lower incidence of adverse effects, less effect on the bacterial flora, improved patient and parent satisfaction, and lower drug costs. In conclusion, short courses of amoxicillin, cephalosporins, and macrolides provide superior or equal efficacy to a 10-day course of penicillin therapy in the treatment of GABHS pharyngotonsillitis.


Asunto(s)
Antibacterianos/uso terapéutico , Faringitis/tratamiento farmacológico , Infecciones Estreptocócicas/tratamiento farmacológico , Streptococcus pyogenes/aislamiento & purificación , Tonsilitis/tratamiento farmacológico , Enfermedad Aguda , Amoxicilina/administración & dosificación , Amoxicilina/uso terapéutico , Antibacterianos/administración & dosificación , Azitromicina/administración & dosificación , Azitromicina/uso terapéutico , Cefalosporinas/administración & dosificación , Cefalosporinas/uso terapéutico , Niño , Humanos , Penicilinas/administración & dosificación , Penicilinas/uso terapéutico , Faringitis/complicaciones , Faringitis/microbiología , Infecciones Estreptocócicas/microbiología , Streptococcus pyogenes/efectos de los fármacos , Tonsilitis/complicaciones , Tonsilitis/microbiología
10.
Psiquis (Madr.) ; 21(2): 75-80, mar. 2000.
Artículo en Es | IBECS | ID: ibc-10903

RESUMEN

Se hace una revisión sobre la importancia de los acontecimientos vitales ya sean recientes o acumulativos en la aparición y o exacerbación de enfermedades físicas (inflamación de garganta, hernias, apendicitis), el dolor crónico (cefaleas, abdominalgias, dolor en el pecho, etc.) y enfermedades crónicas en la infancia y adolescencia (diabetes, asma, fibrosis cistica, hemofilia, artritis reumatoide, herpes) (AU)


Asunto(s)
Adolescente , Femenino , Preescolar , Masculino , Niño , Humanos , Estrés Psicológico , Dolor/psicología , Estrés Fisiológico/complicaciones , Estrés Fisiológico/psicología , Susceptibilidad a Enfermedades/psicología , Capacidad Vital/fisiología , Fuerza Vital , Estudios Retrospectivos , Faringitis/complicaciones , Faringitis/psicología , Hernia/complicaciones , Hernia/psicología , Apendicitis/complicaciones , Apendicitis/psicología , Dolor/complicaciones , Dolor/psicología , Dolor en el Pecho/complicaciones , Dolor en el Pecho/psicología , Diabetes Mellitus/complicaciones , Diabetes Mellitus/psicología , Fibrosis/complicaciones , Fibrosis/psicología , Artritis Reumatoide/complicaciones , Artritis Reumatoide/psicología , Herpes Zóster/complicaciones , Herpes Zóster/psicología , Cefalea/complicaciones , Cefalea/psicología , Hemofilia A/complicaciones , Hemofilia A/psicología
11.
Pediátrika (Madr.) ; 20(3): 89-97, mar. 2000.
Artículo en Es | IBECS | ID: ibc-12034

RESUMEN

Chlamydia pneumoniae ha sido identificado como una importante causa de enfermedades respiratorias en humanos. Este patógeno es transmitido persona a persona por transmisión aérea mediante secrecciones respiratorias. La infección es rara en niños menores de dos años, incrementándose la incidencia en edades escolares. Se estima que aproximadamente el 40 por ciento-60 por ciento de los adultos tienen anticuerpos contra C. pneumoniae. El diagnóstico se basa en la serología, normalmente microinmunofluorescencia (MIF), pero últimamente han aparecido nuevos métodos nuevos como PCR y cultivos mejorados. En niños, C. pneumoniae puede causar una variedad de enfermedades respiratorias como bronquitis, neumonía, sinusitis y faringitis. En los últimos años, se ha relacionado C. pneumoniae con una larga lista de enfermedades, incluyendo las enfermedades cardiovasculares. La hipótesis de que la infección en edades tempranas pueda dar lugar al desarrollo de arteriosclerosis en adultos está siendo evaluada actualmente. Si se confirma, la asociación reportada entre C. pneumoniae y arteriosclerosis podría llevar a el tratamiento de algunas enfermedades cardiovasculares con antibióticos como los macrólidos o las tetraciclinas, que son comúnmente activos contra la infección por C. pneumoniae (AU)


Asunto(s)
Adolescente , Adulto , Femenino , Preescolar , Lactante , Masculino , Niño , Humanos , Recién Nacido , Técnica del Anticuerpo Fluorescente , Técnica del Anticuerpo Fluorescente/métodos , Arteriosclerosis/diagnóstico , Arteriosclerosis/tratamiento farmacológico , Arteriosclerosis/complicaciones , Macrólidos/aislamiento & purificación , Macrólidos/uso terapéutico , Enfermedades Respiratorias/complicaciones , Enfermedades Respiratorias/diagnóstico , Enfermedades Respiratorias/tratamiento farmacológico , Tetraciclinas/uso terapéutico , Conjuntivitis/complicaciones , Conjuntivitis/diagnóstico , Conjuntivitis/terapia , Infecciones por Chlamydia/diagnóstico , Infecciones por Chlamydia/etiología , Infecciones por Chlamydia/terapia , Infecciones por Chlamydia/prevención & control , Chlamydophila pneumoniae/aislamiento & purificación , Chlamydophila pneumoniae/clasificación , Chlamydophila pneumoniae/patogenicidad , Chlamydia , Bronquitis/complicaciones , Bronquitis/diagnóstico , Bronquitis/tratamiento farmacológico , Sinusitis/complicaciones , Sinusitis/diagnóstico , Sinusitis/tratamiento farmacológico , Faringitis/complicaciones , Faringitis/diagnóstico , Faringitis/tratamiento farmacológico , Profilaxis Antibiótica , Neumonía/complicaciones , Neumonía/diagnóstico , Neumonía/tratamiento farmacológico , Neumonía , Neumonía/congénito
13.
Br J Haematol ; 89(3): 610-4, 1995 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-7734361

RESUMEN

Idiopathic purpura fulminans usually occurs in young children and is frequently preceded by a preparatory viral or bacterial infection. Following a severe streptococcal pharyngitis, an 8-year-old boy developed purpura fulminans with disseminated intravascular coagulation and severe protein S deficiency (total antigen < 0.05 u/ml). Despite generous plasma infusions, skin necrosis progressed rapidly into compartment syndrome which required fasciotomy and skin grafting and resulted in the loss of three digits of the right foot. Total protein S remained low for over a month despite plasma supplementation and complete normalization of protein C levels. A polyclonal anti-protein S IgG was demonstrated in the patient's plasma, which decreased to 25% of baseline titre after 1 month and was undetectable 6 months after purpura fulminans, when plasma protein S had returned to normal. Transient, isolated and severe deficiencies of protein S have been reported in patients with idiopathic purpura fulminans and a previous preparatory infection. Autoimmune protein S deficiency may play a key role in the aetiopathogenesis of idiopathic purpura fulminans.


Asunto(s)
Enfermedades Autoinmunes/complicaciones , Vasculitis por IgA/etiología , Faringitis/complicaciones , Deficiencia de Proteína S/complicaciones , Infecciones Estreptocócicas/complicaciones , Autoanticuerpos/sangre , Niño , Coagulación Intravascular Diseminada/etiología , Humanos , Inmunoglobulina G/sangre , Masculino , Necrosis , Proteína C/metabolismo , Proteína S/inmunología , Piel/patología
15.
Harefuah ; 126(11): 651-4, 691, 1994 Jun 01.
Artículo en Hebreo | MEDLINE | ID: mdl-7926999

RESUMEN

Necrotizing fasciitis of the head and neck is a rare infection caused by a mixed bacterial flora with anaerobic predominance. Mortality is due to misdiagnosis which results in late and inadequate treatment. The natural course of this serious infection involves spreading necrosis of the soft tissues of the neck with erosion of major blood vessels. A 33-year-old man and a 66-year-old woman are presented to demonstrate the usual etiological factors of cervical necrotizing fasciitis, mainly dental and pharyngeal infections. Diagnosis is by bacteriological culture and CT-scan; a high degree of clinical suspicion is necessary. Treatment included aggressive surgery, appropriate antibiotic coverage and hyperbaric oxygen, and resulted in successful outcomes in our 2 cases.


Asunto(s)
Fascitis , Cuello , Adulto , Anciano , Antibacterianos/uso terapéutico , Infecciones Bacterianas/microbiología , Terapia Combinada , Caries Dental/complicaciones , Fascitis/diagnóstico , Fascitis/etiología , Fascitis/terapia , Femenino , Humanos , Oxigenoterapia Hiperbárica , Masculino , Necrosis , Faringitis/complicaciones , Resultado del Tratamiento
16.
Antibiot Khimioter ; 37(5): 44-6, 1992 May.
Artículo en Ruso | MEDLINE | ID: mdl-1417331

RESUMEN

The clinical efficacy of a vilozen and ketotifen (zaditen) combination in the treatment of streptococcal infections along with the routine therapy was studied. The use of the combination was shown advisable in the complex therapy and prevention of relapses in patients with streptococcal infections. The combined pharmacotherapy promoted better clinical indices, normalization of the immune status and a reduction in the incidence of allergic reactions to antibiotics and a decrease in sensitization to bacterial allergens.


Asunto(s)
Hipersensibilidad a las Drogas/prevención & control , Erisipela/tratamiento farmacológico , Inmunosupresores/administración & dosificación , Cetotifen/administración & dosificación , Lincomicina/administración & dosificación , Penicilina G/administración & dosificación , Faringitis/tratamiento farmacológico , Infecciones Estreptocócicas/tratamiento farmacológico , Extractos del Timo/administración & dosificación , Adyuvantes Inmunológicos , Hipersensibilidad a las Drogas/etiología , Erisipela/complicaciones , Erisipela/inmunología , Humanos , Lincomicina/efectos adversos , Lincomicina/antagonistas & inhibidores , Penicilina G/efectos adversos , Penicilina G/antagonistas & inhibidores , Faringitis/complicaciones , Faringitis/inmunología , Infecciones Estreptocócicas/complicaciones , Infecciones Estreptocócicas/inmunología
18.
Rev Med Chir Soc Med Nat Iasi ; 86(1): 69-71, 1982.
Artículo en Rumano | MEDLINE | ID: mdl-25591253

RESUMEN

As part of a clinical-epidemiological follow-up carried out between 1975 and 1979 in Iasi, the evolution of the clinical and functional recuperatory process in a series of 269 patients with articular rheumatismal manifestations, out of which 67.6% caused by pharyngo-amigdalytis infections, was studied. The investigations on ASLO, fibrinogen, VSH, urinary sediment, ECG and presence of some germs, having etiological significance, in the nasopharyngeal exudate have brought data pleading for the infectious-allergic etiopathogenesis of an important number of the chronic articular rheumatism cases. The drug treatment and balneophysiotherapy had full recuperatory effects in 18.2% and partial ones in 57.6% of the cases. The cost of the recuperatory intervention is about 4-4,500 lei/year/patient.


Asunto(s)
Artritis Reumatoide/microbiología , Artritis Reumatoide/rehabilitación , Infecciones Estreptocócicas/complicaciones , Tonsilitis/complicaciones , Adulto , Antiestreptolisina/sangre , Artritis Reumatoide/sangre , Artritis Reumatoide/diagnóstico , Artritis Reumatoide/economía , Artritis Reumatoide/epidemiología , Balneología/métodos , Biomarcadores/sangre , Sedimentación Sanguínea , Electrocardiografía , Femenino , Fibrinógeno/metabolismo , Estudios de Seguimiento , Humanos , Factores Inmunológicos/sangre , Masculino , Persona de Mediana Edad , Faringitis/complicaciones , Modalidades de Fisioterapia , Estudios Prospectivos , Estudios Retrospectivos , Rumanía/epidemiología , Tonsilitis/microbiología , Resultado del Tratamiento , Orina/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA